71 results
Page 2 of 4
6-K
EX-99.3
qr50ip6ifq
5 Mar 15
Current report (foreign)
12:00am
6-K
EX-99
vqa7ehcu 43kp0
9 Feb 15
2015 Annual General Meeting of Shareholders
12:00am
6-K
EX-99
jw280d4o72ctprfyy
5 Nov 14
BioLineRx Announces Successful Final Results of
12:00am
6-K
EX-99
00yekztkujaat
21 Aug 14
BioLineRx Receives Notice of Allowance for US Patent on BL-7010
12:00am
6-K
EX-99
15o98h kasg
16 Jul 14
BioLineRx Announces Results from
12:00am
424B2
h5rpfwzqyvqbb0
13 Jun 14
Prospectus for primary offering
12:00am
6-K
EX-1
k3hrk
11 Jun 14
Current report (foreign)
12:00am
F-3
2y4mdgrs510
30 May 14
Shelf registration (foreign)
12:00am
6-K
EX-99
3gm8 z21pih723sz345q
10 Mar 14
BioLineRx Completes Dose Escalation Stage of Phase 1/2 Study
12:00am
424B5
m30yhw7
4 Mar 14
Prospectus supplement for primary offering
12:00am
424B5
cw67lxc
3 Mar 14
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
zr8c3 glhzav
3 Mar 14
Current report (foreign)
12:00am
6-K
EX-99
odfelwte
18 Dec 13
Current report (foreign)
12:00am
6-K
EX-99
hrkdbe1jx3os1yuhrg2l
4 Nov 13
BioLineRx Receives Regulatory Approval to Commence
12:00am
6-K
EX-99
mi1e2dfc
24 Sep 13
BioLineRx Announces Regulatory Submission for Phase
12:00am
424B3
9sy4yqmzhousz2de3
8 Aug 13
Prospectus supplement
12:00am
6-K
EX-99
40d06q
30 Apr 13
Current report (foreign)
12:00am
6-K
EX-99
rqgo3 1vsu7f
20 Mar 13
Current report (foreign)
12:00am